SG11201809007YA - Substituted fused pyrimidinone compounds - Google Patents
Substituted fused pyrimidinone compoundsInfo
- Publication number
- SG11201809007YA SG11201809007YA SG11201809007YA SG11201809007YA SG11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA
- Authority
- SG
- Singapore
- Prior art keywords
- torrent
- bhat
- dist
- tal
- gujarat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621014526 | 2016-04-26 | ||
| PCT/IB2017/052352 WO2017187324A1 (en) | 2016-04-26 | 2017-04-25 | Substituted fused pyrimidinone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809007YA true SG11201809007YA (en) | 2018-11-29 |
Family
ID=58745288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809007YA SG11201809007YA (en) | 2016-04-26 | 2017-04-25 | Substituted fused pyrimidinone compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190127381A1 (ja) |
| EP (1) | EP3448855A1 (ja) |
| JP (1) | JP2019514906A (ja) |
| KR (1) | KR20180135486A (ja) |
| CN (1) | CN109071515A (ja) |
| AR (1) | AR108327A1 (ja) |
| AU (1) | AU2017256175A1 (ja) |
| BR (1) | BR112018072063A2 (ja) |
| CA (1) | CA3021542A1 (ja) |
| EA (1) | EA201892370A1 (ja) |
| IL (1) | IL262363A (ja) |
| MX (1) | MX2018012966A (ja) |
| PH (1) | PH12018502246A1 (ja) |
| SG (1) | SG11201809007YA (ja) |
| TW (1) | TW201806953A (ja) |
| WO (1) | WO2017187324A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7450541B2 (ja) | 2018-01-20 | 2024-03-15 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | 置換アミノピリミジン化合物及び使用方法 |
| CN111269231B (zh) * | 2018-12-04 | 2023-06-09 | 安徽中科拓苒药物科学研究有限公司 | 一种选择性PI3Kδ抑制剂及其用途 |
| CN116987085A (zh) * | 2022-04-26 | 2023-11-03 | 安徽中科拓苒药物科学研究有限公司 | 一种PI3Kδ抑制剂及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2760012B1 (fr) | 1997-02-26 | 2000-08-18 | Oreal | Compositions pour la teinture des fibres keratiniques contenant des para-aminophenols, procede de teinture, nouveaux para-aminophenols et leur procede de prepraration |
| MXPA03008560A (es) * | 2001-03-22 | 2004-06-30 | Abbot Gmbh & Co Kg | Pirazolopirimidinas como agentes terapeuticos. |
| MX2010007418A (es) | 2008-01-04 | 2010-11-12 | Intellikine Inc | Ciertas entidades quimicas, composiciones y metodos. |
| WO2012037204A1 (en) | 2010-09-14 | 2012-03-22 | Exelixis, Inc. | Inhibitors of pi3k-delta and methods of their use and manufacture |
| WO2012040634A1 (en) * | 2010-09-24 | 2012-03-29 | Gilead Calistoga Llc | Atropisomers of pi3k-inhibiting compounds |
| UY33337A (es) * | 2010-10-18 | 2011-10-31 | Respivert Ltd | DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS |
-
2017
- 2017-04-19 TW TW106113084A patent/TW201806953A/zh unknown
- 2017-04-25 WO PCT/IB2017/052352 patent/WO2017187324A1/en active Application Filing
- 2017-04-25 CN CN201780025852.8A patent/CN109071515A/zh active Pending
- 2017-04-25 BR BR112018072063A patent/BR112018072063A2/pt not_active Application Discontinuation
- 2017-04-25 EA EA201892370A patent/EA201892370A1/ru unknown
- 2017-04-25 KR KR1020187033910A patent/KR20180135486A/ko unknown
- 2017-04-25 AU AU2017256175A patent/AU2017256175A1/en not_active Abandoned
- 2017-04-25 MX MX2018012966A patent/MX2018012966A/es unknown
- 2017-04-25 CA CA3021542A patent/CA3021542A1/en not_active Abandoned
- 2017-04-25 SG SG11201809007YA patent/SG11201809007YA/en unknown
- 2017-04-25 JP JP2018555987A patent/JP2019514906A/ja active Pending
- 2017-04-25 EP EP17724911.7A patent/EP3448855A1/en not_active Withdrawn
- 2017-04-25 US US16/095,597 patent/US20190127381A1/en not_active Abandoned
- 2017-04-26 AR ARP170101057A patent/AR108327A1/es unknown
-
2018
- 2018-10-14 IL IL262363A patent/IL262363A/en unknown
- 2018-10-22 PH PH12018502246A patent/PH12018502246A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017187324A9 (en) | 2018-12-06 |
| JP2019514906A (ja) | 2019-06-06 |
| US20190127381A1 (en) | 2019-05-02 |
| BR112018072063A2 (pt) | 2019-02-12 |
| MX2018012966A (es) | 2019-01-17 |
| EP3448855A1 (en) | 2019-03-06 |
| KR20180135486A (ko) | 2018-12-20 |
| AR108327A1 (es) | 2018-08-08 |
| PH12018502246A1 (en) | 2019-08-19 |
| WO2017187324A1 (en) | 2017-11-02 |
| CA3021542A1 (en) | 2017-11-02 |
| EA201892370A1 (ru) | 2019-03-29 |
| AU2017256175A1 (en) | 2018-11-15 |
| CN109071515A (zh) | 2018-12-21 |
| TW201806953A (zh) | 2018-03-01 |
| IL262363A (en) | 2018-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201805838UA (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201811414TA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201804170RA (en) | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders | |
| SG11201408821SA (en) | Selective pi3k delta inhibitors | |
| SG11201907544VA (en) | Jak inhibitors containing a 4-membered heterocyclic amide | |
| SG11201803627XA (en) | N-substituted indole derivatives as pge2 receptor modulators | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201408750VA (en) | NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS | |
| SG11201408237YA (en) | Compound as wnt signaling inhibitor, composition, and use thereof | |
| SG11201407546QA (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
| SG11201909376TA (en) | Crystalline forms of a jak inhibitor compound | |
| SG11201810389XA (en) | New antibacterial compounds | |
| SG11201900633XA (en) | Piperidine cxcr7 receptor modulators | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201407326XA (en) | Compositions and methods for treatment of mucositis | |
| SG11201804589TA (en) | Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201407184PA (en) | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals | |
| SG11201804774YA (en) | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031 | |
| SG11201900689RA (en) | Compounds and compositions and uses thereof | |
| SG11201908097YA (en) | Pyrimidine derivatives as pge2 receptor modulators | |
| SG11201903091VA (en) | Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors |